Cargando…

Production of a viral surface protein in Nannochloropsis oceanica for fish vaccination against infectious pancreatic necrosis virus

ABSTRACT: Nannochloropsis oceanica is a unicellular oleaginous microalga of emerging biotechnological interest with a sequenced, annotated genome, available transcriptomic and proteomic data, and well-established basic molecular tools for genetic engineering. To establish N. oceanica as a eukaryotic...

Descripción completa

Detalles Bibliográficos
Autores principales: Rout, Sweta Suman, de Grahl, Imke, Yu, Xiaohong, Reumann, Sigrun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9449291/
https://www.ncbi.nlm.nih.gov/pubmed/36069927
http://dx.doi.org/10.1007/s00253-022-12106-7
_version_ 1784784262874005504
author Rout, Sweta Suman
de Grahl, Imke
Yu, Xiaohong
Reumann, Sigrun
author_facet Rout, Sweta Suman
de Grahl, Imke
Yu, Xiaohong
Reumann, Sigrun
author_sort Rout, Sweta Suman
collection PubMed
description ABSTRACT: Nannochloropsis oceanica is a unicellular oleaginous microalga of emerging biotechnological interest with a sequenced, annotated genome, available transcriptomic and proteomic data, and well-established basic molecular tools for genetic engineering. To establish N. oceanica as a eukaryotic host for recombinant protein synthesis and develop molecular technology for vaccine production, we chose the viral surface protein 2 (VP2) of a pathogenic fish virus that causes infectious pancreatic necrosis as a model vaccine. Upon stable nuclear transformation of N. oceanica strain CCMP1779 with the codon-optimized VP2 gene, a Venus reporter fusion served to evaluate the strength of different endogenous promoters in transformant populations by qPCR and flow cytometry. The highest VP2 yields were achieved for the elongation factor promoter, with enhancer effects by its N-terminal leader sequence. Individual transformants differed in their production capability of reporter-free VP2 by orders of magnitude. When subjecting the best candidates to kinetic analyses of growth and VP2 production in photobioreactors, recombinant protein integrity was maintained until the early stationary growth phase, and a high yield of 4.4% VP2 of total soluble protein was achieved. The maximum yield correlated with multiple integrations of the expression vector into the nuclear genome. The results demonstrate that N. oceanica was successfully engineered to constitute a robust platform for high-level production of a model subunit vaccine. The molecular methodology established here can likely be adapted in a straightforward manner to the production of further vaccines in the same host, allowing their distribution to fish, vertebrates, or humans via a microalgae-containing diet. KEY POINTS: • We engineered N. oceanica for recombinant protein production. • The antigenic surface protein 2 of IPN virus could indeed be expressed in the host. • A high yield of 4.4% VP2 of total soluble protein was achieved in N. oceanica. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00253-022-12106-7.
format Online
Article
Text
id pubmed-9449291
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-94492912022-09-07 Production of a viral surface protein in Nannochloropsis oceanica for fish vaccination against infectious pancreatic necrosis virus Rout, Sweta Suman de Grahl, Imke Yu, Xiaohong Reumann, Sigrun Appl Microbiol Biotechnol Applied Genetics and Molecular Biotechnology ABSTRACT: Nannochloropsis oceanica is a unicellular oleaginous microalga of emerging biotechnological interest with a sequenced, annotated genome, available transcriptomic and proteomic data, and well-established basic molecular tools for genetic engineering. To establish N. oceanica as a eukaryotic host for recombinant protein synthesis and develop molecular technology for vaccine production, we chose the viral surface protein 2 (VP2) of a pathogenic fish virus that causes infectious pancreatic necrosis as a model vaccine. Upon stable nuclear transformation of N. oceanica strain CCMP1779 with the codon-optimized VP2 gene, a Venus reporter fusion served to evaluate the strength of different endogenous promoters in transformant populations by qPCR and flow cytometry. The highest VP2 yields were achieved for the elongation factor promoter, with enhancer effects by its N-terminal leader sequence. Individual transformants differed in their production capability of reporter-free VP2 by orders of magnitude. When subjecting the best candidates to kinetic analyses of growth and VP2 production in photobioreactors, recombinant protein integrity was maintained until the early stationary growth phase, and a high yield of 4.4% VP2 of total soluble protein was achieved. The maximum yield correlated with multiple integrations of the expression vector into the nuclear genome. The results demonstrate that N. oceanica was successfully engineered to constitute a robust platform for high-level production of a model subunit vaccine. The molecular methodology established here can likely be adapted in a straightforward manner to the production of further vaccines in the same host, allowing their distribution to fish, vertebrates, or humans via a microalgae-containing diet. KEY POINTS: • We engineered N. oceanica for recombinant protein production. • The antigenic surface protein 2 of IPN virus could indeed be expressed in the host. • A high yield of 4.4% VP2 of total soluble protein was achieved in N. oceanica. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00253-022-12106-7. Springer Berlin Heidelberg 2022-09-07 2022 /pmc/articles/PMC9449291/ /pubmed/36069927 http://dx.doi.org/10.1007/s00253-022-12106-7 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/ Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Applied Genetics and Molecular Biotechnology
Rout, Sweta Suman
de Grahl, Imke
Yu, Xiaohong
Reumann, Sigrun
Production of a viral surface protein in Nannochloropsis oceanica for fish vaccination against infectious pancreatic necrosis virus
title Production of a viral surface protein in Nannochloropsis oceanica for fish vaccination against infectious pancreatic necrosis virus
title_full Production of a viral surface protein in Nannochloropsis oceanica for fish vaccination against infectious pancreatic necrosis virus
title_fullStr Production of a viral surface protein in Nannochloropsis oceanica for fish vaccination against infectious pancreatic necrosis virus
title_full_unstemmed Production of a viral surface protein in Nannochloropsis oceanica for fish vaccination against infectious pancreatic necrosis virus
title_short Production of a viral surface protein in Nannochloropsis oceanica for fish vaccination against infectious pancreatic necrosis virus
title_sort production of a viral surface protein in nannochloropsis oceanica for fish vaccination against infectious pancreatic necrosis virus
topic Applied Genetics and Molecular Biotechnology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9449291/
https://www.ncbi.nlm.nih.gov/pubmed/36069927
http://dx.doi.org/10.1007/s00253-022-12106-7
work_keys_str_mv AT routswetasuman productionofaviralsurfaceproteininnannochloropsisoceanicaforfishvaccinationagainstinfectiouspancreaticnecrosisvirus
AT degrahlimke productionofaviralsurfaceproteininnannochloropsisoceanicaforfishvaccinationagainstinfectiouspancreaticnecrosisvirus
AT yuxiaohong productionofaviralsurfaceproteininnannochloropsisoceanicaforfishvaccinationagainstinfectiouspancreaticnecrosisvirus
AT reumannsigrun productionofaviralsurfaceproteininnannochloropsisoceanicaforfishvaccinationagainstinfectiouspancreaticnecrosisvirus